NSC |
Compound |
Enrichment |
Correlation |
NSC 114346 |
Null |
0.0352383000003056 |
0.25548981 |
NSC 119915 |
3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid |
0.0352383000003056 |
0.48253945 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0352383000003056 |
0.19178429 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0352383000003056 |
0.24923823 |
NSC 244404 |
Null |
0.0352383000003056 |
0.20525981 |
NSC 263434 |
N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine |
0.0352383000003056 |
0.31408352 |
NSC 300289 |
Pinafide |
0.0352383000003056 |
0.28000853 |
NSC 303861 |
L-Cysteine analog |
0.0352383000003056 |
0.55199239 |
NSC 32951 |
Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone |
0.0352383000003056 |
0.1452018 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0352383000003056 |
0.43508206 |